- Report
- July 2024
- 97 Pages
Global
From €3500EUR$4,183USD£3,139GBP
- Report
- February 2024
- 103 Pages
Global
From €3500EUR$4,183USD£3,139GBP
- Report
- July 2023
- 81 Pages
Global
From €3500EUR$4,183USD£3,139GBP
- Report
- November 2025
- 132 Pages
Global
From €852EUR$950USD£738GBP
- Report
- November 2025
- 132 Pages
Global
From €852EUR$950USD£738GBP
- Report
- January 2025
- 132 Pages
Global
From €852EUR$950USD£738GBP
- Report
- January 2025
- 132 Pages
Global
From €852EUR$950USD£738GBP
- Report
- January 2025
- 132 Pages
Global
From €852EUR$950USD£738GBP
- Report
- November 2021
- 1112 Pages
Global
From €5379EUR$6,000USD£4,660GBP
- Report
- November 2021
- 545 Pages
Global
From €3586EUR$4,000USD£3,107GBP
- Report
- November 2021
- 233 Pages
Global
From €2241EUR$2,500USD£1,942GBP
The Digital Polymerase Chain Reaction (dPCR) market is a subset of the genomics industry. It is a technology used to detect and quantify nucleic acid molecules, such as DNA and RNA. It is a highly sensitive and specific method for detecting and quantifying nucleic acid molecules, and is used in a variety of applications, including gene expression analysis, genotyping, and diagnostics. dPCR is also used in research and development, as well as in clinical settings.
dPCR is a cost-effective and efficient method for detecting and quantifying nucleic acid molecules, and is becoming increasingly popular in the genomics industry. It is used in a variety of applications, including gene expression analysis, genotyping, and diagnostics.
Some companies in the dPCR market include Bio-Rad, Thermo Fisher Scientific, Agilent Technologies, QIAGEN, and Illumina. Show Less Read more